Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA.

Hirsch TZ, Negulescu A, Gupta B, Caruso S, Noblet B, Couchy G, Bayard Q, Meunier L, Morcrette G, Scoazec JY, Blanc JF, Amaddeo G, Nault JC, Bioulac-Sage P, Ziol M, Beaufrère A, Paradis V, Calderaro J, Imbeaud S, Zucman-Rossi J.

J Hepatol. 2019 Dec 17. pii: S0168-8278(19)30718-4. doi: 10.1016/j.jhep.2019.12.006. [Epub ahead of print]

PMID:
31862487
2.

Non-invasive fibrosis tests to predict complications in compensated post-hepatitis C cirrhosis.

Zarski JP, David-Tchouda S, Trocme C, Margier J, Vilotitch A, Hilleret MN, Cagnot C, Boursier V, Ziol M, Sutton A, Layese R, Audureau E, Roudot-Thoraval F, Nahon P.

Clin Res Hepatol Gastroenterol. 2019 Dec 12. pii: S2210-7401(19)30256-6. doi: 10.1016/j.clinre.2019.11.005. [Epub ahead of print]

PMID:
31839535
3.

TNFR2 associates with FoxP3 stability and identifies asubset of regulatory T cells that are specifically expanded by anti-TNF treatments in rheumatoid arthritis.

Santinon F, Batignes M, Mebrek M, Biton J, Gaëlle C, Hervé R, Lemeiter D, Breckler M, Busato F, Tost J, Ziol M, Boissier MC, Decker P, Semerano L, Bessis N.

Arthritis Rheumatol. 2019 Oct 14. doi: 10.1002/art.41134. [Epub ahead of print]

PMID:
31609517
4.

Dynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinoma.

Rochigneux P, Nault JC, Mallet F, Chretien AS, Barget N, Garcia AJ, Del Pozo L, Bourcier V, Blaise L, Grando-Lemaire V, N'Kontchou G, Nahon P, Seror O, Ziol M, Ganne-Carrié N, Olive D.

Oncoimmunology. 2019 May 25;8(8):1615818. doi: 10.1080/2162402X.2019.1615818. eCollection 2019.

5.

ESM1 as a Marker of Macrotrabecular-Massive Hepatocellular Carcinoma.

Calderaro J, Meunier L, Nguyen CT, Boubaya M, Caruso S, Luciani A, Amaddeo G, Regnault H, Nault JC, Cohen J, Oberti F, Michalak S, Bouattour M, Vilgrain V, Pageaux GP, Ramos J, Barget N, Guiu B, Paradis V, Aubé C, Laurent A, Pawlotsky JM, Ganne-Carrié N, Zucman-Rossi J, Seror O, Ziol M.

Clin Cancer Res. 2019 Oct 1;25(19):5859-5865. doi: 10.1158/1078-0432.CCR-19-0859. Epub 2019 Jul 29.

PMID:
31358545
6.

Late onset of nivolumab-induced severe gastroduodenitis and cholangitis in a patient with stage IV melanoma.

Cǎlugǎreanu A, Rompteaux P, Bohelay G, Goldfarb L, Barrau V, Cucherousset N, Heidelberger V, Nault JC, Ziol M, Caux F, Maubec E.

Immunotherapy. 2019 Aug;11(12):1005-1013. doi: 10.2217/imt-2019-0077. Epub 2019 Jul 15.

PMID:
31304833
7.

Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosis.

Rekik S, Allaire M, Mumana A, Guyot E, Nkontchou G, Grando V, Blaise L, Ziol M, Nahon P, Ganne-Carrié N, Sutter O, Seror O, Nault JC.

J Gastroenterol Hepatol. 2020 Jan;35(1):142-150. doi: 10.1111/jgh.14763. Epub 2019 Jul 31.

PMID:
31237018
8.

Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma.

Nault JC, Martin Y, Caruso S, Hirsch TZ, Bayard Q, Calderaro J, Charpy C, Copie-Bergman C, Ziol M, Bioulac-Sage P, Couchy G, Blanc JF, Nahon P, Amaddeo G, Ganne-Carrie N, Morcrette G, Chiche L, Duvoux C, Faivre S, Laurent A, Imbeaud S, Rebouissou S, Llovet JM, Seror O, Letouzé E, Zucman-Rossi J.

Hepatology. 2020 Jan;71(1):164-182. doi: 10.1002/hep.30811. Epub 2019 Aug 12.

PMID:
31206197
9.

Molecular and histological correlations in liver cancer.

Calderaro J, Ziol M, Paradis V, Zucman-Rossi J.

J Hepatol. 2019 Sep;71(3):616-630. doi: 10.1016/j.jhep.2019.06.001. Epub 2019 Jun 10. Review.

PMID:
31195064
10.

A Constitutional Activating MET Mutation Makes the Genetic Link between Malignancies and Chronic Inflammatory Diseases.

El Bouchtaoui M, Do Cruzeiro M, Leboeuf C, Loisel-Ferreira I, Fedronie C, Ferreira C, Ait El Far R, Ziol M, Espié M, Falgarone G, Cassinat B, Kiladjian JJ, Feugeas JP, Janin A, Bousquet G.

Clin Cancer Res. 2019 Jul 15;25(14):4504-4515. doi: 10.1158/1078-0432.CCR-18-3261. Epub 2019 Apr 19.

PMID:
31004003
11.

A 17-Beta-Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver Disease.

Yang J, Trépo E, Nahon P, Cao Q, Moreno C, Letouzé E, Imbeaud S, Bayard Q, Gustot T, Deviere J, Bioulac-Sage P, Calderaro J, Ganne-Carrié N, Laurent A, Blanc JF, Guyot E, Sutton A, Ziol M, Zucman-Rossi J, Nault JC.

Hepatology. 2019 Jul;70(1):231-240. doi: 10.1002/hep.30623. Epub 2019 Apr 25.

PMID:
30908678
12.

Benign liver tumors

Blaise L, Sutter O, Ziol M, Nault JC.

Rev Prat. 2018 Dec;68(10):1119-1124. French.

PMID:
30869222
13.

Elevated adiponectin and sTNFRII serum levels can predict progression to hepatocellular carcinoma in patients with compensated HCV1 cirrhosis.

Bastard JP, Fellahi S, Audureau É, Layese R, Roudot-Thoraval F, Cagnot C, Mahuas-Bourcier V, Sutton A, Ziol M, Capeau J, Nahon P; ANRS CO12 CirVir group.

Eur Cytokine Netw. 2018 Sep 1;29(3):112-120. doi: 10.1684/ecn.2018.0413.

PMID:
30547888
14.

Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.

Sermondade N, Sonigo C, Sifer C, Valtat S, Ziol M, Eustache F, Grynberg M.

Fertil Steril. 2019 Feb;111(2):357-362. doi: 10.1016/j.fertnstert.2018.10.018. Epub 2018 Dec 7.

PMID:
30527837
15.

Molecular classification of hepatocellular adenomas: impact on clinical practice.

Védie AL, Sutter O, Ziol M, Nault JC.

Hepat Oncol. 2018 Apr 9;5(1):HEP04. doi: 10.2217/hep-2017-0023. eCollection 2018 Jan. Review.

16.

PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases.

Yang J, Trépo E, Nahon P, Cao Q, Moreno C, Letouzé E, Imbeaud S, Gustot T, Deviere J, Debette S, Amouyel P, Bioulac-Sage P, Calderaro J, Ganne-Carrié N, Laurent A, Blanc JF, Guyot E, Sutton A, Ziol M, Zucman-Rossi J, Nault JC.

Int J Cancer. 2019 Feb 1;144(3):533-544. doi: 10.1002/ijc.31910. Epub 2018 Nov 9.

17.

Correction to: Ileocolic intussusception due to a cecal endometriosis: Case report and review of literature.

Rivkine E, Marciano L, Polliand C, Valenti A, Ziol M, Poncelet C, Barrat C.

Diagn Pathol. 2018 Aug 24;13(1):58. doi: 10.1186/s13000-018-0723-y.

18.

Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosis.

Allaire M, Rekik S, Layese R, Mumana A, Guyot E, Nkontchou G, Bourcier V, Grando V, Ziol M, Nahon P, Ganne-Carrié N, Sutter O, Audureau E, Seror O, Nault JC.

Dig Liver Dis. 2019 Jan;51(1):86-94. doi: 10.1016/j.dld.2018.07.014. Epub 2018 Jul 24.

PMID:
30126822
19.

Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis.

Nguyen-Khac E, Thiele M, Voican C, Nahon P, Moreno C, Boursier J, Mueller S, de Ledinghen V, Stärkel P, Gyune Kim S, Fernandez M, Madsen B, Naveau S, Krag A, Perlemuter G, Ziol M, Chatelain D, Diouf M.

Lancet Gastroenterol Hepatol. 2018 Sep;3(9):614-625. doi: 10.1016/S2468-1253(18)30124-9. Epub 2018 Jul 6.

PMID:
29983372
20.

Micromolecular methods for diagnosis and therapeutic strategy: a case study.

Elbouchtaoui M, Tengher I, Miquel C, Brugière C, Benbara A, Zelek L, Ziol M, Bouhidel F, Janin A, Bousquet G, Leboeuf C.

Oncotarget. 2018 Apr 27;9(32):22862-22869. doi: 10.18632/oncotarget.25161. eCollection 2018 Apr 27.

21.

Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients.

Cacoub P, Nahon P, Layese R, Blaise L, Desbois AC, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Capron D, Thiefin G, Zucman D, Di Martino V, Bagnis CI, Ziol M, Sutton A, Letouze E, Roudot-Thoraval F, Audureau E; ANRS CO12 CirVir group.

Am Heart J. 2018 Apr;198:4-17. doi: 10.1016/j.ahj.2017.10.024. Epub 2017 Nov 7.

PMID:
29653647
22.

Influence of Progenitor-Derived Regeneration Markers on Hepatitis C Virus-Related Cirrhosis Outcome (ANRS CO12 CirVir Cohort).

Wendum D, Layese R, Ganne-Carrié N, Bourcier V, Merabtene F, Cagnot C, Sauce E, Barget N, Bedossa P, Terris B, Selves J, Bioulac-Sage P, Sturm N, Sattonnet C, Nahon P, Roudot-Thoraval F, Ziol M; ANRS CO12 CirVir Group.

Hepatology. 2018 Oct;68(4):1534-1548. doi: 10.1002/hep.29927.

23.

Determination of candidate metabolite biomarkers associated with recurrence of HCV-related hepatocellular carcinoma.

Liu Z, Nahon P, Li Z, Yin P, Li Y, Amathieu R, Ganne-Carrié N, Ziol M, Sellier N, Seror O, Le Moyec L, Savarin P, Xu G.

Oncotarget. 2017 Dec 15;9(5):6245-6258. doi: 10.18632/oncotarget.23500. eCollection 2018 Jan 19.

24.

Hsp72 protects against liver injury via attenuation of hepatocellular death, oxidative stress, and JNK signaling.

Levada K, Guldiken N, Zhang X, Vella G, Mo FR, James LP, Haybaeck J, Kessler SM, Kiemer AK, Ott T, Hartmann D, Hüser N, Ziol M, Trautwein C, Strnad P.

J Hepatol. 2018 May;68(5):996-1005. doi: 10.1016/j.jhep.2018.01.003. Epub 2018 Jan 11.

PMID:
29331340
25.

Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance.

Ziol M, Poté N, Amaddeo G, Laurent A, Nault JC, Oberti F, Costentin C, Michalak S, Bouattour M, Francoz C, Pageaux GP, Ramos J, Decaens T, Luciani A, Guiu B, Vilgrain V, Aubé C, Derman J, Charpy C, Zucman-Rossi J, Barget N, Seror O, Ganne-Carrié N, Paradis V, Calderaro J.

Hepatology. 2018 Jul;68(1):103-112. doi: 10.1002/hep.29762. Epub 2018 May 9.

PMID:
29281854
26.

Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan.

Roulot D, Roudot-Thoraval F, NKontchou G, Kouacou N, Costes JL, Elourimi G, Le Clesiau H, Ziol M, Beaugrand M.

Liver Int. 2017 Dec;37(12):1897-1906. doi: 10.1111/liv.13481. Epub 2017 Jul 2.

PMID:
28556413
27.

Autoimmune-like chronic hepatitis induced by olmesartan.

Barge S, Ziol M, Nault JC.

Hepatology. 2017 Dec;66(6):2086-2088. doi: 10.1002/hep.29228. Epub 2017 Oct 30. No abstract available.

PMID:
28437842
28.

Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity In Vitro.

Rebouissou S, La Bella T, Rekik S, Imbeaud S, Calatayud AL, Rohr-Udilova N, Martin Y, Couchy G, Bioulac-Sage P, Grasl-Kraupp B, de Koning L, Ganne-Carrié N, Nault JC, Ziol M, Zucman-Rossi J.

Clin Cancer Res. 2017 Aug 1;23(15):4364-4375. doi: 10.1158/1078-0432.CCR-16-3118. Epub 2017 Feb 28.

29.

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.

Nahon P, Bourcier V, Layese R, Audureau E, Cagnot C, Marcellin P, Guyader D, Fontaine H, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Leroy V, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Dharancy S, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle C, Dao T, Benhamou Y, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Zucman D, Di Martino V, Thibaut V, Salmon D, Ziol M, Sutton A, Pol S, Roudot-Thoraval F; ANRS CO12 CirVir Group.

Gastroenterology. 2017 Jan;152(1):142-156.e2. doi: 10.1053/j.gastro.2016.09.009. Epub 2016 Sep 15. Erratum in: Gastroenterology. 2019 Feb 25;:.

PMID:
27641509
30.

Reply to Rokx et al.

Le Joncour A, Bidegain F, Ziol M, Nebbad B, Galicier L, Oksenhendler E, Mechai F, Boutboul D, Bouchaud O.

Clin Infect Dis. 2016 Aug 1;63(3):428. doi: 10.1093/cid/ciw304. Epub 2016 May 8. No abstract available.

PMID:
27161782
31.

Keratin 23 is a stress-inducible marker of mouse and human ductular reaction in liver disease.

Guldiken N, Kobazi Ensari G, Lahiri P, Couchy G, Preisinger C, Liedtke C, Zimmermann HW, Ziol M, Boor P, Zucman-Rossi J, Trautwein C, Strnad P.

J Hepatol. 2016 Sep;65(3):552-9. doi: 10.1016/j.jhep.2016.04.024. Epub 2016 May 2.

PMID:
27151178
32.

Sequential Serum Metabolomic Profiling after Radiofrequency Ablation of Hepatocellular Carcinoma Reveals Different Response Patterns According to Etiology.

Goossens C, Nahon P, Le Moyec L, Triba MN, Bouchemal N, Amathieu R, Ganne-Carrié N, Ziol M, Trinchet JC, Sellier N, Diallo A, Seror O, Savarin P.

J Proteome Res. 2016 May 6;15(5):1446-54. doi: 10.1021/acs.jproteome.5b01032. Epub 2016 Apr 14.

PMID:
27015127
33.

Percutaneous Treatment of Localized Infiltrative Hepatocellular Carcinoma Developing on Cirrhosis.

Nault JC, Nkontchou G, Nahon P, Grando V, Bourcier V, Barge S, Ziol M, Sellier N, Ganne-Carrie N, Seror O.

Ann Surg Oncol. 2016 Jun;23(6):1906-15. doi: 10.1245/s10434-015-5064-4. Epub 2016 Jan 5.

PMID:
26732275
34.

Hemophagocytic Lymphohistiocytosis Associated With Bartonella henselae Infection in an HIV-Infected Patient.

Le Joncour A, Bidegain F, Ziol M, Galicier L, Oksenhendler E, Mechai F, Boutboul D, Bouchaud O.

Clin Infect Dis. 2016 Mar 15;62(6):804-6. doi: 10.1093/cid/civ999. Epub 2015 Dec 8.

PMID:
26646679
35.

Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B.

Cardoso AC, Beaugrand M, de Ledinghen V, Douvin C, Poupon R, Trinchet JC, Ziol M, Bedossa P, Marcellin P.

Ann Hepatol. 2015 Nov-Dec;14(6):826-36. doi: 10.5604/16652681.1171762.

36.

Prevalence and clinical significance of nodular regenerative hyperplasia in liver biopsies.

Barge S, Grando V, Nault JC, Broudin C, Beaugrand M, Ganne-Carrié N, Roulot D, Ziol M.

Liver Int. 2016 Jul;36(7):1059-66. doi: 10.1111/liv.12974. Epub 2015 Oct 19.

PMID:
26415006
37.

Norepinephrine Decreases Fluid Requirements and Blood Loss While Preserving Intestinal Villi Microcirculation during Fluid Resuscitation of Uncontrolled Hemorrhagic Shock in Mice.

Harrois A, Baudry N, Huet O, Kato H, Dupic L, Lohez M, Ziol M, Vicaut E, Duranteau J.

Anesthesiology. 2015 May;122(5):1093-102. doi: 10.1097/ALN.0000000000000639.

PMID:
25782753
38.

Genetic risk markers for hepatocellular carcinoma in patients with alcoholic liver disease.

Nahon P, Sutton A, Ziol M, Zucman-Rossi J, Trinchet JC, Ganne-Carrié N.

Hepat Oncol. 2015 Jan;2(1):63-78. doi: 10.2217/hep.14.26. Epub 2015 Jan 12. Review.

39.

Aseptic muscular abscesses associated with myelodysplastic syndrome.

Mirouse A, Virone A, Gobert D, Soussan M, Braun T, Ziol M, Gardin C, Fenaux P, Mekinian A, Fain O.

Eur J Dermatol. 2014 Nov-Dec;24(6):696-7. doi: 10.1684/ejd.2014.2435. No abstract available.

PMID:
25333797
40.

Predicting recurrence following radiofrequency percutaneous ablation for hepatocellular carcinoma.

Ganne-Carrié N, Nault JC, Ziol M, N'Kontchou G, Nahon P, Grando V, Bourcier V, Barge S, Beaugrand M, Trinchet JC, Seror O.

Hepat Oncol. 2014 Oct;1(4):395-408. doi: 10.2217/hep.14.22. Epub 2014 Dec 11. Review.

41.

Keratins 8 and 18 are type II acute-phase responsive genes overexpressed in human liver disease.

Guldiken N, Usachov V, Levada K, Trautwein C, Ziol M, Nahon P, Strnad P.

Liver Int. 2015 Apr;35(4):1203-12. doi: 10.1111/liv.12608. Epub 2014 Jun 26.

PMID:
24930437
42.

Impact of cytokine gene variants on the prediction and prognosis of hepatocellular carcinoma in patients with cirrhosis.

Tarhuni A, Guyot E, Rufat P, Sutton A, Bourcier V, Grando V, Ganne-Carrié N, Ziol M, Charnaux N, Beaugrand M, Moreau R, Trinchet JC, Mansouri A, Nahon P.

J Hepatol. 2014 Aug;61(2):342-50. doi: 10.1016/j.jhep.2014.04.011. Epub 2014 Apr 18.

PMID:
24751829
43.

High frequency of X chromosome abnormalities in women with short stature and elevated liver enzymes.

Roulot D, Malan V, Ziol M, Linglart A, Bourcier V, Beaugrand M, Benzacken B.

J Clin Endocrinol Metab. 2014 Aug;99(8):E1592-6. doi: 10.1210/jc.2014-1037. Epub 2014 Apr 14.

PMID:
24731013
44.

Relationship between tumor heterogeneity measured on FDG-PET/CT and pathological prognostic factors in invasive breast cancer.

Soussan M, Orlhac F, Boubaya M, Zelek L, Ziol M, Eder V, Buvat I.

PLoS One. 2014 Apr 10;9(4):e94017. doi: 10.1371/journal.pone.0094017. eCollection 2014.

45.

GH administration rescues fatty liver regeneration impairment by restoring GH/EGFR pathway deficiency.

Collin de l'Hortet A, Zerrad-Saadi A, Prip-Buus C, Fauveau V, Helmy N, Ziol M, Vons C, Billot K, Baud V, Gilgenkrantz H, Guidotti JE.

Endocrinology. 2014 Jul;155(7):2545-54. doi: 10.1210/en.2014-1010. Epub 2014 Apr 7.

PMID:
24708244
46.

Synergistic deleterious effect of hypoxemia and hypovolemia on microcirculation in intestinal villi*.

Harrois A, Baudry N, Huet O, Kato H, Lohez M, Ziol M, Duranteau J, Vicaut E.

Crit Care Med. 2013 Nov;41(11):e376-84. doi: 10.1097/CCM.0b013e318292388d.

PMID:
23963129
47.

ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.

Ziol M, Sutton A, Calderaro J, Barget N, Aout M, Leroy V, Blanc JF, Sturm N, Bioulac-Sage P, Nahon P, Nault JC, Charnaux N, N'kontchou G, Trinchet JC, Delehedde M, Seror O, Beaugrand M, Vicaut E, Ganne-Carrié N.

J Hepatol. 2013 Dec;59(6):1264-70. doi: 10.1016/j.jhep.2013.07.030. Epub 2013 Aug 6.

PMID:
23928407
48.

Systematic cavity shaving: modifications of breast cancer management and long-term local recurrence, a multicentre study.

Héquet D, Bricou A, Koual M, Ziol M, Feron JG, Rouzier R, Brouland JP, Delpech Y, Barranger E.

Eur J Surg Oncol. 2013 Aug;39(8):899-905. doi: 10.1016/j.ejso.2013.05.012. Epub 2013 Jun 15.

PMID:
23773800
49.

Malignant transformation of abdominal wall endometriosis: case report and literature review.

Vinchant M, Poncelet C, Ziol M, Vons C, Bricou A.

Tumori. 2013 Mar-Apr;99(2):e49-54. doi: 10.1700/1283.14207. Review.

PMID:
23748829
50.

Q fever and Mediterranean spotted fever associated with hemophagocytic syndrome: case study and literature review.

Lecronier M, Prendki V, Gerin M, Schneerson M, Renvoisé A, Larroche C, Ziol M, Fain O, Mekinian A.

Int J Infect Dis. 2013 Aug;17(8):e629-33. doi: 10.1016/j.ijid.2012.12.026. Epub 2013 Feb 9. Review.

Supplemental Content

Support Center